Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Cardiovascular medicaments put up in measured doses or in forms for retail sale
Medicaments, n.E.S., in dosage form or retail packings
Pharmaceutical preparations
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICU - Precious metal content is unknown
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
058770 - Drugs/medicines/vitamins noi
532 - Drugs and medicines excluding pencillin, sulfa, serums, vaccines, and vitamins (not requiring temperature control)
9 - Other or no special handling required (sh)
A - Shipment is not a consolidation and does not exceed 84 inches in any dimension.
M - Medical supplies, equipment, samples, records, etc.
W - Rating variable
Z - No special type of cargo code applicable
Questions & Answers: |
|
What are the historical prices recorded for this stock number? | |
No pre-dated pricing for this NSN could be found. | |
Does NSN 6505-00-115-0052 have a shelf life? | |
No. There is no shelf life applicable for this NSN. | |
What NATO entities are users of this NSN? | |
Veterans Administration | |
What is the NIIN of NSN 6505-00-115-0052? | |
001150052 or 00-115-0052 | |
Does NSN 6505-00-115-0052 require demilitarization? | |
Yes - ITAR Controlled | |
What is the most recent solicitation for NSN 6505-00-115-0052? | |
No solicitations for this NSN. | |
When was this national stock number assigned to the federal catalog? | |
Sep 20, 1968 |
Routes of entry: inhalation: yes skin: yes ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: ingestion: toxic effects on central
nervous system/cardiovascular system. Skin: allergic reaction.
inhalation: mucous membrane irritation, numbness, loss of
sensation, nervousness, confusion, drowsine ss, vomiting, tremors,
convulsions, respiratory depression/unconsciousness. Eyes:
irritation & blurred vision.
explanation of carcinogenicity: none
effects of overexposure: inhalation: slowing of heart/blood pressure
drop, unconsciousness, nervousness, confusion, drowsiness,
vomiting, tremors, convulsion, respiratory depression, mucous
membrane irritation, numbness & los s of sensation. Ingestion:
toxic effects on cns/cardiovascular system. Skin: allergic
reaction. Eye: blurred vision.
medical cond aggravated by exposure: allergic reaction/hypersensitivity.
First aid: eyes: wash thoroughly w/clean water for 15 minutes.
inhalation: if breathing & control convulsion. Call physician.
Boiling pt: b.P. Text: 100c
melt/freeze pt: m.P/f.P text: 0
vapor pres: 17
vapor density: 0.6
spec gravity: 1
evaporation rate & reference: (water = 1): 1
solubility in water: soluble
appearance and odor: clear liquid, odorless in ampul
Stability indicator/materials to avoid: yes
reacts violently w/water
stability condition to avoid: extreme temperatures
hazardous decomposition products: none
Waste disposal methods: dispose as a non-hazardous waste.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: lidocaine hydrochloride
cas: 73-78-9
rtecs #: an7600000
fraction by wt: 1%